We continue our myeloma series, transitioning our discussion from autologous stem cell transplant to maintenance therapy for myeloma.Content:- Why do we use revlimid (lenalidomide) maintenance?- What about in high risk patients?- What is the role of MRD testing?- What about daratumumab in the maintenance setting? This episode has been sponsored by Primum. To sign up for a free account, check out: tfoc.primum.co.Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast